基于络病学说探讨虫类药在糖尿病肾脏病中的应用OA
Overview of the Application of Insect-Based Medicines in Diabetic Nephropathy Based on the Theory of Collateral Epidemiology
随着糖尿病发病率逐年增长,糖尿病肾脏病的流行率也持续上升,已经成为慢性肾衰竭的主要原因之一,是全人类共同的公共卫生难题.近年来部分医家从肾络亏虚、癥瘕阻络、毒损肾络、玄府郁闭等方面探讨糖尿病肾脏病的发病机制,为糖尿病肾脏病的诊治提供新的方向.虫类药具有逐瘀散结、搜风剔络、荣养通络的作用,其走窜之性、通络之功在糖尿病肾脏病络病诊治中发挥标本兼治的综合疗效.该文梳理分析近五年相关文献,从络脉与肾脏微血管的联系、糖尿病肾脏病的络病病机及虫类药治疗糖尿病肾脏病的机制、通路和靶点作一综述,拓宽糖尿病肾脏病的诊疗及用药思路.
With the increasing incidence of diabetes mellitus,the prevalence of diabetic nephropathy has also been rising,becoming one of the main causes of chronic renal failure and a common public health challenge for all man-kind.In recent years,some physicians have explored the pathogenesis of diabetic nephropathy from aspects such as kidney deficiency,abdominal masses obstructing the collaterals,toxic damage to the kidney collaterals,and stagna-tion of the pores,providing new directions for the diagnosis and treatment of diabetic nephropathy.Insect-based drugs have the effects of dispelling blood stasis and resolving masses,clearing wind and removing obstructions,and nourish-ing and unblocking the collaterals.Their penetrating nature and collateral-unblocking function play a comprehensive role in the diagnosis and treatment of collateral diseases in diabetic nephropathy,addressing both the symptoms and the root cause.This article reviews and analyzes relevant literature from the past five years,summarizing the connec-tion between collaterals and renal micro-vessels,the pathogenesis of collateral diseases in diabetic nephropathy,and the mechanisms,pathways,and targets of insect-based drugs in the treatment of diabetic nephropathy,broadening the ideas for the diagnosis,treatment,and medication of diabetic nephropathy.
赵小露;杨晓琨;高颖
天津中医药大学第一附属医院,中医国家临床医学研究中心,国家中医针灸临床医学研究中心 天津 300381天津中医药大学第一附属医院,中医国家临床医学研究中心,国家中医针灸临床医学研究中心 天津 300381天津中医药大学第一附属医院,中医国家临床医学研究中心,国家中医针灸临床医学研究中心 天津 300381
医药卫生
糖尿病肾脏病消渴病络病学说虫类药
Diabetic nephropathyDiabetes mellitusCollateral disease theoryInsect-based drugs
《中医药临床杂志》 2026 (3)
430-435,6
天津市深化医药卫生体制改革研究项目(2022YG18)
评论